AIDS-related events and deaths occur even in HIV-infected patients with high CD4-cell counts; whether this means treatment should be started earlier is not certain.
When should antiretroviral therapy (ART) be started in HIV-infected patients? Current treatment guidelines suggest that ART be considered when the CD4 count falls below 350 cells/mm3 or the viral load exceeds 100,000 copies/mL. Now that treatments have become less toxic, many clinicians are thinking of starting therapy in patients with higher CD4-cell counts. To examine this issue, researchers analyzed the risk for AIDS events and death in treatment-naive HIV-infected patients seen in any of 10 U.K. clinics (17,609 patients; 30,313 person-years of follow-up).
Among patients with CD4 counts >350 cells/mm3, rates of severe AIDS-related events or death were 0.79-fold lower per 100 cells/mm3 higher CD4 count (P<0.001). Significant differences we…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)